TiGRT IVS is intended to be used in conjunction with Linac and Digital Panel for analyzing the current patient position and calculating the patient positioning shift correction factor, as well as the treatment portal verification and record.

Device Description

AI/ML Overview

The provided text does not contain any information about acceptance criteria or a study proving the device meets acceptance criteria.

The document is a 510(k) premarket notification for an image viewing system called TiGRT IVS. It primarily focuses on demonstrating substantial equivalence to a predicate device (ExacTrac K072046) based on intended use, design, and performance characteristics.

Here's what the document does include:

Device Name: TiGRT IVS
Intended Use: To be used in conjunction with Linac and Digital Panel for analyzing the current patient position, calculating patient positioning shift correction factor, and for treatment portal verification and record.
Predicate Device: ExacTrac (K072046)
Classification: Class II device (21 CFR 892.5050)
Comparison with Predicate Device: A table comparing characteristics like operating system, networking, intended use, application, and DICOM compatibility. All characteristics are either identical or considered substantially equivalent.

Therefore, I cannot provide the requested information in the table format because the source text does not contain it. This type of document (a 510(k) summary) focuses on substantial equivalence rather than explicit performance data against acceptance criteria.

Summary

{0}------------------------------------------------

K09255D

Summary of Safety and Effectiveness

July 20, 2009

1. Submitter's Information

Common/Usual Name:

Image Viewing System

Proprietary Name:

TiGRT IVS, TiGRT

DEC 1 5 2009

Applicant Name and Address:

LinaTech, LLC 1294 Kifer Road, #705 Sunnyvale, CA 94086 Telephone: 408-733-2051 Fax: 408-733-2045

2. Predicate Devices

ExacTrac (K072046)

3. Classification

This device is classified as a Class II device according to 21 CFR 892.5050.

4. Performance Standards

No applicable standards have been established by FDA under section 514 of the Food, Drug and Cosmetic Act.

{1}------------------------------------------------

5. Intended Use and Device Description

The intended use is the same as the predicate device.

6. Biocompatibilitv

No new issues of biocompatibility are raised with regard to this device.

7. Summary of Substantial Equivalence

This device is similar in design and construction, and has the same intended use and performance characteristics to the predicate device. It utilizes materials that are already in use in other medical devices. No new issues of safety or effectiveness are introduced by using this device.

{2}------------------------------------------------

Table 1: Comparison of TiGRT IVS Modified Device with Predicate Device

: 上

. .

Characteristic	Current ModifiedDevice TIGRT IVS	Predicate DeviceExacTrac (K072046)
OperatingSystem	Windows XP / Vista/7	Windows XP Professional
Networking	TCP/IP	TCP/IP
Intended Use	TiGRT IVS isintended to be usedin conjunction withLinac and DigitalPanel for analyzingthe current patientposition andcalculating thepatient positioningshift correctionfactor, as well as thetreatment portalverification andrecord.	The ExacTrac 3rd party system isintended to be used in conjunctionwith the MHI-TM2000 radiationtherapy linear accelerator systemmanufactured by Mitsubishi HeavyIndustries, Ltd. ExacTrac 3rd Partyuses the images received from theMHI-TM2000 linear accelerator foranalyzing the current patient positionand calculating - when applicable - anecessary correction shift. Thecorrection shift is then exported to theMHI-TM2000 linear accelerator.The ExacTrac 3rd Party system usesstereoscopic x-ray or cone beam CTregistration and optical tracking ofinfrared reflective markers in order tolocalize and correct the patientposition before and during treatment.
Application(Use)	Patient tracking andpositioning,Portal verificationand record,	Patient tracking and positioning,Portal verification and record.
DICOM	DICOM 3/RT	DICOM 3/RT

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an emblem of an eagle.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002

Jonathan Yao, Ph.D. President and CEO LinaTech LLC 1294 Kifer Road, Suite 705 SUNNYVALE CA 94086

DEC 1 5 2009

Re: K092550

Trade/Device Name: TiGRT IVS Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: IYE Dated: October 30, 2009 Received: November 5, 2009

Dear Dr. Yao:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations; Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

{4}------------------------------------------------

Page 2 -

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm

Sincerely yours,

Janine M. Morris

Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Page 1 of 1

510(k) Number (if known): K092550

Device Name:____TiGRT IVS

Indications for Use:

(PLEASE DO NOT WRITE BELLOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Optional Format 3-10-98)

Prescription Use ____________________________(Per 21 CFR 801.109)

_
(Division Sign-Off)

Division of Reproductive, Abdominal and Radiological Devices 510 (k) Number _

Regulation Number and Section

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.